1-7 of 7
Lars R. Fransecky, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Interim Results of a Multicenter, Single-Arm Study to Assess Blinatumomab in Adult Patients (pts) with Minimal Residual Disease (MRD) of B-Precursor (BCP) Acute Lymphoblastic Leukemia (GMALL-MOLACT1-BLINA)

Nicola Goekbuget, MD, Wiba Keke Wermann, Stefan Schwartz, MD PhD, Andreas Hüttmann, MD, Christoph Faul, MD, Simon Raffel, MD, Andreas Viardot, Professor Dr, Walter Fiedler, MD, Nael Alakel, MD, Matthias Stelljes, MD, Marion Subklewe, MD, Ralph Wäsch, Sonja Martin, MD, Wolfram Jung, MD, Vladan Vucinic, MD, Mustafa Kondakci, MD, Lars R. Fransecky, MD, Daniela Heidenreich, MD, Knut Wendelin, MD, Julian Hermann, Hubert Serve, MD PhD, Ralf C Bargou, MD PhD, Max S. Topp, MD, Monika Brüggemann, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 39–40.
https://doi.org/10.1182/blood-2020-137350
Published: 2020
Journal Articles

Impact of Genetic Abnormalities and Measurable Residual Disease Levels on Outcome in Patients with MDS/AML Pre-Emptively Treated with Azacitidine: Correlative Results of the Prospective RELAZA2 Trial

Sabine Kayser, MD, Jan Moritz Middeke, MD, Michael Kramer, Katja Sockel, MD, Sebastian Stasik, PhD, Regina Herbst, MD, Lars R. Fransecky, MD, Dominik Wolf, Univ. Prof. Dr., Schumacher Martin, MD, Alwin Krämer, MD, Richard Noppeney, MD, Juergen Novotny, MD, Gesine Bug, Katharina S. Götze, Karsten Spiekermann, MD, Matthias Stelljes, MD, Jan-Henrik Mikesch, PD, MD, Marion Subklewe, MD, Antje Schubert, Anke Mütherig, MD, Tilmann Bochtler, MD, Marika Mende, MD, Friedrich Stoelzel, PD, MD, Anne Kubasch, MD, Malte Von Bonin, MD, Mathias Haenel, MD, Ulrich Duehrsen, MD, Johannes Schetelig, MDMSc, Christoph Rollig, MD MSC, Claudia D Baldus, MD, Gerhard Ehninger, MD, Carsten Müller-Tidow, MD, Hubert Serve, MD PhD, Martin Bornhäuser, MD, Uwe Platzbecker, Christian Thiede, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 10–11.
https://doi.org/10.1182/blood-2020-138427
Published: 2020
Journal Articles

Molecular Subgroups of T Cell Acute Lymphoblastic Leukemia in Adults Treated According to GMALL Protocols

Martin Neumann, Lorenz Bastian, Sonja Hänzelmann, Alina Hartmann, Heiko Trautmann, PhD, Jutta Ortiz Tanchez, Cornelia Schlee, Michael P Schroeder, PhD, Lars R. Fransecky, MD, Sebastian Vosberg, Walter Fiedler, MD, Nael Alakel, MD, Mustafa Kondakci, MD, Michael Starck, MD, Stefan Schwartz, MD PhD, Carsten Müller-Tidow, MD, Folker Schneller, Albert Reichle, Thomas Burmeister, Philipp A. Greif, MD PD, Monika Brüggemann, MD, Nicola Goekbuget, MD, Claudia D Baldus, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 37–38.
https://doi.org/10.1182/blood-2020-141921
Published: 2020
Journal Articles

Time from Diagnosis to Treatment Does Not Affect Outcome in Intensively Treated Patients with Newly Diagnosed Acute Myeloid Leukemia

Christoph Röllig, MD MSC, Michael Kramer, M.Sc., Christoph Schliemann, Jan-Henrik Mikesch, MD, Björn Steffen, MD, Alwin Krämer, MD, Tim Sauer, MD, Mathias Hänel, MD, Regina Herbst, MD, Kerstin Schäfer-Eckart, MD, Richard Noppeney, MD, Edgar Jost, MD, Tim H Brümmendorf, MD, Stefan W Krause, MD, Volker Kunzmann, MD PhD, Hermann Einsele, MD, Sebastian Scholl, Andreas Hochhaus, MD, Lars R. Fransecky, MD, Martin Kaufmann, MD, Andreas Neubauer, MD, Dirk Niemann, MD, Markus Schaich, MD, Norbert Frickhofen, MD, Alexander Kiani, Frank Heits, MD, Ulrich Krümpelmann, Ulrich Kaiser, MD, Johannes Kullmer, Maxi Wass, MD, Stefan Klein, MD, Malte Von Bonin, Jan Moritz Middeke, MD, Christian Thiede, MD, Friedrich Stoelzel, MD, Johannes Schetelig, MDMSc, Gerhard Ehninger, MD, Claudia D Baldus, Carsten Müller-Tidow, MD, Uwe Platzbecker, Hubert Serve, MD, Martin Bornhäuser, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 13.
https://doi.org/10.1182/blood-2019-123717
Published: 2019
Journal Articles

Azacitidine for Pre-Emptive Treatment of Measurable-Residual Disease in MDS/AML Patients at High Risk of Hematological Relapse: Results of the Second Cohort of the RELAZA2 Trial

Uwe Platzbecker, MD, Jan Moritz Middeke, MD, Katja Sockel, MD, Regina Herbst, MD, Lars R. Fransecky, MD, Dominik Wolf, MD, Schumacher Martin, MD, Alwin Krämer, MD, Richard Noppeney, MD, Juergen Novotny, MD, Gesine Bug, Katharina Götze, Karsten Spiekermann, MD, Matthias Stelljes, MD, Christoph Groth, MD, Marion Subklewe, MD, Antje Schubert, Anke Mütherig, MD, Tilmann Bochtler, MD, Marika Mende, MD, Anne Sophie Kubasch, MD, Mathias Hänel, MD, Ulrich Dührsen, Prof, MD PhD, Johannes Schetelig, MD MSc, Christoph Röllig, MD MSC, Claudia D Baldus, Gerhard Ehninger, MD, Carsten Müller-Tidow, MD, Hubert Serve, MD, Michael Kramer, M.Sc., Martin Bornhäuser, MD, Christian Thiede, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 644.
https://doi.org/10.1182/blood-2019-129926
Published: 2019
Journal Articles

DNMT3A Mutations in AML Patients: Prognostic Impact and Comparative Analysis of Mutations Burden in Diagnostic Samples, after Standard Therapy, and after Allogeneic Stem Cell Transplantation

Olga Blau, MD PhD, Franziska Behrenbeck, Nikola Suckert, Lars R. Fransecky, MD, Claudia D. Baldus, MD, Renate Arnold, MD PhD, Antonio Pezzutto, MD PhD, Bernd Dörken, MD PhD, Igor Wolfgang Blau, MD PhD
Journal: Blood
Blood (2016) 128 (22): 2891.
https://doi.org/10.1182/blood.V128.22.2891.2891
Published: 2016
Journal Articles

CDK4/6 Inhibitor Palbociclib for Treatment of KMT2A -Rearranged Acute Myeloid Leukemia: Interim Analysis of the AMLSG 23-14 Trial

Stefan Fröhling, MD, Mridul Agrawal, MD, Nikolaus Jahn, MD, Lars R. Fransecky, MD, Claudia D. Baldus, MD, Ralph Wäsch, MD, Michael Lübbert, MD, Gina Walter, PhD, Patrizia Jensen, Claudia Scholl, MD, Marianne Habdank, Konstanze Döhner, Hartmut Döhner, MD, Richard F. Schlenk, MD
Journal: Blood
Blood (2016) 128 (22): 1608.
https://doi.org/10.1182/blood.V128.22.1608.1608
Published: 2016